Evaluation of baseline subject clinical characteristics showed that subjects meeting early disease definition No.1 had a mean of 1.1 (median 0.0) months from NV-AMD diagnosis to baseline assessment while those who did not meet the definition for early disease had a mean of 3.1 (median 0.0) months, a difference that did not reach statistical significance in either the mean or the median.
← all excerpts
Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study.
1
—
—